|
1
|
Heinrikson RL, Krueger ET and Keim PS:
Amino acid sequence of phospholipase A2-alpha from the venom of
Crotalus adamanteus. A new classification of phospholipases A2
based upon structural determinants. J Biol Chem. 252:4913–4921.
1977.PubMed/NCBI
|
|
2
|
de Beer FC and Webb NR: Inflammation and
atherosclerosis: Group IIa and Group V sPLA2 are not redundant.
Arterioscler Thromb Vasc Biol. 26:1421–1422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Starkl P, Marichal T and Galli SJ: PLA2G3
promotes mast cell maturation and function. Nat Immunol.
14:527–529. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mackenzie LS, Lymn JS and Hughes AD:
Linking phospholipase C isoforms with differentiation function in
human vascular smooth muscle cells. Biochim Biophys Acta.
1833.3006–3012. 2013.
|
|
5
|
Clark JD, Schievella AR, Nalefski EA and
Lin LL: Cytosolic phospholipase A2. J Lipid Mediat Cell Signal.
12:83–117. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johansson P and Thesleff S: A comparison
of the effects of phos-pholipase C and tetrodotoxin on spike
generation in muscle. Eur J Pharmacol. 4:347–348. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jackson TN, Sunagar K, Undheim EA, et al:
Venom down under: dynamic evolution of Australian elapid snake
toxins. Toxins (Basel). 5:2621–2655. 2013. View Article : Google Scholar
|
|
8
|
Margres MJ, Aronow K, Loyacano J and
Rokyta DR: The venom-gland transcriptome of the eastern coral snake
(Micrurus fulvius) reveals high venom complexity in the
intragenomic evolution of venoms. BMC Genomics. 14(531): 2013
|
|
9
|
Dennis EA: Diversity of group types,
regulation, and function of phospholipase A2. J Biol Chem.
269:13057–13060. 1994.PubMed/NCBI
|
|
10
|
Smith AD and Winkler H: Lysosomal
phospholipases A1 and A2 of bovine adrenal medulla. Biochem J.
108:867–874. 1968.PubMed/NCBI
|
|
11
|
Pan YH, Yu BZ, Berg OG, Jain MK and
Bahnson BJ: Crystal structure of phospholipase A2 complex with the
hydrolysis products of platelet activating factor: equilibrium
binding of fatty acid and lysophospholipid-ether at the active site
may be mutually exclusive. Biochemistry. 41:14790–14800. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohtsuki T, Watanabe H, Toru M and Arinami
T: Lack of evidence for associations between plasma
platelet-activating factor acetyl-hydrolase deficiency and
schizophrenia. Psychiatry Res. 109:93–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hixon MS, Ball A and Gelb MH:
Calcium-dependent and -independent interfacial binding and
catalysis of cytosolic group IV phospholipase A2. Biochemistry.
37:8516–8526. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Retraction: CDP-choline significantly
restores phosphatidylcholine levels by differentially affecting
phospholipase A2 and CTP: phosphocholine cytidylyltransferase after
stroke. J Biol Chem. 288(7549): 2013
|
|
15
|
Fitzpatrick AL, Irizarry MC, Cushman M,
Jenny NS, Chi GC and Koro C: Lipoprotein-associated phospholipase
A2 and risk of dementia in the Cardiovascular Health Study.
Atherosclerosis. 235:384–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gui YX, Xu ZP, Wen-Lv Q, Liu HM, Zhao JJ
and Hu XY: Four novel rare mutations of PLA2G6 in Chinese
population with Parkinson's disease. Parkinsonism Relat Disord.
19:21–26. 2013. View Article : Google Scholar
|
|
17
|
Farooqui AA, Ong WY and Horrocks LA:
Inhibitors of brain phospholipase A2 activity: their
neuropharmacological effects and therapeutic importance for the
treatment of neurologic disorders. Pharmacol Rev. 58:591–620. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holmes MV, Simon T, Exeter HJ, et al:
Secretory phospholipase A(2)-IIA and cardiovascular disease: a
mendelian randomization study. J Am Coll Cardiol. 62:1966–1976.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohno M, Menez R, Ogawa T, et al: Molecular
evolution of snake toxins: is the functional diversity of snake
toxins associated with a mechanism of accelerated evolution? Prog
Nucleic Acid Res Mol Biol. 59:307–364. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edgar RC: MUSCLE: a multiple sequence
alignment method with reduced time and space complexity. BMC
Bioinformatics. 5(113): 2004
|
|
21
|
Suyama M, Torrents D and Bork P: PAL2NAL:
robust conversion of protein sequence alignments into the
corresponding codon alignments. Nucleic Acids Res. 34:W609–W612.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kumar S, Tamura K and Nei M: MEGA3:
Integrated software for Molecular Evolutionary Genetics Analysis
and sequence alignment. Brief Bioinform. 5:150–163. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Posada D: Using MODELTEST and
PAUP* to select a model of nucleotide substitution. Curr
Protoc Bioinformatics. Chapter 6: Unit 6.5. 2003.
|
|
24
|
Guindon S and Gascuel O: A simple, fast,
and accurate algorithm to estimate large phylogenies by maximum
likelihood. Syst Biol. 52:696–704. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Posada D and Crandall KA: MODELTEST:
testing the model of DNA substitution. Bioinformatics. 14:817–818.
1998. View Article : Google Scholar
|
|
26
|
Ronquist F and Huelsenbeck JP: MrBayes 3:
Bayesian phylogenetic inference under mixed models. Bioinformatics.
19:1572–1574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huelsenbeck JP and Ronquist F: MRBAYES:
Bayesian inference of phylogenetic trees. Bioinformatics.
17:754–755. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Z: PAML 4: phylogenetic analysis by
maximum likelihood. Mol Biol Evol. 24:1586–1591. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Z, Wong WS and Nielsen R: Bayes
empirical bayes inference of amino acid sites under positive
selection. Mol Biol Evol. 22:1107–1118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nielsen R and Yang Z: Likelihood models
for detecting positively selected amino acid sites and applications
to the HIV-1 envelope gene. Genetics. 148:929–936. 1998.PubMed/NCBI
|
|
31
|
Rost B, Yachdav G and Liu J: The
PredictProtein server. Nucleic Acids Res. 32:W321–W326. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roy A, Yang J and Zhang Y: COFACTOR: an
accurate comparative algorithm for structure-based protein function
annotation. Nucleic Acids Res. 40:W471–W477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roy A, Kucukural A and Zhang Y: I-TASSER:
a unified platform for automated protein structure and function
prediction. Nat Protoc. 5:725–738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y: I-TASSER server for protein 3D
structure prediction. BMC Bioinformatics. 9(40): 2008
|
|
35
|
Saitou N and Nei M: The neighbor-joining
method: a new method for reconstructing phylogenetic trees. Mol
Biol Evol. 4:406–425. 1987.PubMed/NCBI
|
|
36
|
Thompson EA: The method of minimum
evolution. Ann Hum Genet. 36:333–340. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goodman M, Moore GW, Barnabas J and
Matsuda G: The phylogeny of human globin genes investigated by the
maximum parsimony method. J Mol Evol. 3:1–48. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xin H, Chen ZY, Lv XB, Liu S, Lian ZX and
Cai SL: Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in
patients surviving acute myocardial infarction. Eur Rev Med
Pharmacol Sci. 17:999–1004. 2013.PubMed/NCBI
|
|
39
|
Sullivan AH: A measurement of the local
energy deposition by antiprotons coming to rest in tissue-like
material. Phys Med Biol. 30:1297–1303. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duivenvoorden R, Mani V, Woodward M, et
al: Relationship of serum inflammatory biomarkers with plaque
inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC
Cardiovasc Imaging. 6:1087–1094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mangili A, Ahmad R, Wolfert RL, et al:
Lipoprotein-associated phospholipase A2, a novel cardiovascular
inflammatory marker, in HIV-infected patients. Clin Infect Dis.
58:893–900. 2014. View Article : Google Scholar
|
|
42
|
Hariprasad G, Srinivasan A and Singh R:
Structural and phylogenetic basis for the classification of group
III phospholipase A2. J Mol Model. 19:3779–3791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Magrioti V and Kokotos G: Phospholipase A2
inhibitors as potential therapeutic agents for the treatment of
inflammatory diseases. Expert Opin Ther Pat. 20:1–18. 2010.
View Article : Google Scholar
|
|
44
|
Gibbs HL and Rossiter W: Rapid evolution
by positive selection and gene gain and loss: PLA2 venom
genes in closely related Sistrurus rattlesnakes with divergent
diets. J Mol Evol. 66:151–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Woodgett JR, Gould KL and Hunter T:
Substrate specificity of protein kinase C. Use of synthetic
peptides corresponding to physiological sites as probes for
substrate recognition requirements. Eur J Biochem. 161:177–184.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pinna LA: Casein kinase 2: an ‘eminence
grise’ in cellular regulation? Biochim Biophys Acta. 1054:267–284.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chapus C, Rovery M, Sarda L and Verger R:
Minireview on pancreatic lipase and colipase. Biochimie.
70:1223–1234. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Caslake MJ and Packard CJ:
Lipoprotein-associated phospholipase A2 (platelet-activating factor
acetylhydrolase) and cardiovascular disease. Curr Opin Lipidol.
14:347–352. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Feng LM, Feng GF and Chen Y: Evaluation of
lipoprotein-associated phospholipase A2 in healthy Chinese Han
adult serum. Lipids Health Dis. 13(6): 2014
|
|
50
|
Harvey EJ, Li N and Ramji DP: Critical
role for casein kinase 2 and phosphoinositide-3-kinase in the
interferon-gamma-induced expression of monocyte chemoattractant
protein-1 and other key genes implicated in atherosclerosis.
Arterioscler Thromb Vasc Biol. 27:806–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tai W, Garcia M, Mlynash M, Kemp S, Albers
GW and Olivot JM: Lipoprotein phospholipase A2 mass and activity
are not associated with the diagnosis of acute brain ischemia.
Cerebrovasc Dis. 38:324–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nozadze DN, Sergienko IV, Balakhonova TV,
Semenova AE, Vlasik TN and Kukharchuk VV: Lipoprotein-associated
phospholipase A2 serum levels in patients from different categories
of cardiovascular risk. Kardiologiia. 54:57–63. 2014.(In
Russian).
|
